MRC Laboratory of Molecular Biology

Migration, Crosslink

📖

MRC Laboratory of Molecular Biology

active

wiki page Created: 2026-04-02T07:20:10 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-institutions-mrc-lmb

📖 Wiki Page

institution2242 wordssynced 2026-04-02

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">MRC Laboratory of Molecular Biology</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>MRC LMB</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Cambridge, United Kingdom</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Public Research Institute</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1962</td>
</tr>
<tr>
<td class="label">Parent Organization</td>
<td>Medical Research Council (MRC)</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.mrc-lmb.cam.ac.uk" target="_blank">mrc-lmb.cam.ac.uk</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Structural Biology, Protein Misfolding, Neurodegeneration, Cryo-EM</td>
</tr>
<tr>
<td class="label">Nobel Laureates</td>
<td>30+</td>
</tr>
</table>

MRC Laboratory of Molecular Biology

Introduction

...

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">MRC Laboratory of Molecular Biology</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>MRC LMB</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Cambridge, United Kingdom</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Public Research Institute</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1962</td>
</tr>
<tr>
<td class="label">Parent Organization</td>
<td>Medical Research Council (MRC)</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.mrc-lmb.cam.ac.uk" target="_blank">mrc-lmb.cam.ac.uk</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Structural Biology, Protein Misfolding, Neurodegeneration, Cryo-EM</td>
</tr>
<tr>
<td class="label">Nobel Laureates</td>
<td>30+</td>
</tr>
</table>

MRC Laboratory of Molecular Biology

Introduction

Mermaid diagram (expand to render)

The MRC Laboratory of Molecular Biology (LMB) is a world-renowned research institute in Cambridge, UK, and one of the world's leading laboratories for molecular biology and structural biology research["@lmb-website"]. Founded in 1962, the LMB has been at the forefront of scientific discovery for over six decades, with researchers having won multiple Nobel Prizes for their work in molecular biology, structural biology, and more recently, neuroscience.

The institute's expertise in structural biology and protein science has made foundational contributions to understanding the molecular mechanisms underlying neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, ALS, and prion diseases.

History and Institutional Development

Origins and Founding (1947-1962)

The MRC Laboratory of Molecular Biology traces its origins to the MRC Unit for the Study of the Molecular Structure of Biological Systems, founded in 1947[@lmb-website]. Under the leadership of pioneering scientists:

Max Perutz: Determined the structure of hemoglobin
John Kendrew: Determined the structure of myoglobin
Frederick Sanger: Developed methods for protein sequencing

In 1962, the unit was reorganized as the MRC Laboratory of Molecular Biology, becoming one of the world's premier research institutes.

Nobel Prize Legacy

The LMB has produced over 30 Nobel laureates affiliated with its research, making it one of the most productive scientific institutions in history:

1962: Max Perutz and John Kendrew (Chemistry)
1968: Frederick Sanger (Chemistry)
1982: Aaron Klug (Chemistry)
1997: John Gurdon (Physiology/Medicine)
2017: Richard Henderson (Chemistry) for cryo-electron microscopy

Modern Era

The LMB continues to be a powerhouse of scientific innovation, particularly in:

Cryo-electron microscopy: Revolutionizing structural biology
Protein folding and misfolding: Understanding disease mechanisms
Neurodegeneration: From structure to therapy
RNA biology: Understanding post-transcriptional regulation
Cell biology: Fundamental cellular mechanisms
Computational biology: AI and machine learning for structure prediction

Research Focus Areas

Neurodegeneration Research

The LMB hosts several groups focused on understanding the molecular mechanisms underlying neurodegenerative diseases[@sweeney2017]:

Protein Misfolding Research

Studies on how misfolded proteins contribute to neurodegeneration[@dobson2003][@bucciantini2012]:

Tau Pathology: Understanding how tau protein forms toxic aggregates in Alzheimer's disease[@fitzpatrick2017]
Alpha-Synuclein: Structure of Parkinson's disease pathology[@guerrero-ferreira2018][@li2018]
TDP-43: Protein aggregates in ALS and frontotemporal dementia[@taylor2019]
Prion Proteins: Fundamental mechanisms of protein misfolding and propagation[@prusiner2013]
Huntingtin: Aggregation in Huntington's disease
SOD1: Amyotrophic lateral sclerosis protein aggregation

Structural Biology

Determination of protein structures involved in neural function and dysfunction[@sawaya2009][@eisenberg2012]:

Cryo-EM: Visualizing protein aggregates at atomic resolution
X-ray Crystallography: Determining protein structures
NMR Spectroscopy: Studying protein dynamics
Single-Particle Reconstruction: Analyzing individual molecules
Tomography: 3D reconstruction of cellular structures

Amyloid Biology

Understanding the structural basis of amyloid formation[@chiti2015]:

Amyloid Fibril Structures: Different conformations in disease
Oligomer Formation: Toxic intermediate species
Strain Diversity: Different aggregate strains in disease[@jensen2020]
Cross-β Architecture: Common structural motif in all amyloids
Polymorphism: How different sequences form different structures

Key Research Contributions

Tau Research

The LMB has made landmark contributions to understanding tau pathology in Alzheimer's disease[@fitzpatrick2017][@barrett2016]:

Cryo-EM Structures: First atomic structures of tau filaments from AD brains
Strain Characterization: Different tau conformations in various tauopathies
Propagation Mechanisms: How tau aggregates spread in the brain
Therapeutic Implications: Structural insights for drug design

Alpha-Synuclein Research

Pioneering structural studies of Parkinson's disease pathology[@guerrero-ferreira2018][@li2018]:

Fibril Structures: Atomic-resolution structures of alpha-synuclein fibrils
Polymorphism: Different fibril strains in disease
Membrane Interactions: How alpha-synuclein interacts with cellular membranes
Seeding: Mechanisms of prion-like propagation

Prion Research

Fundamental discoveries in prion biology[@prusiner2013][@caughey2014]:

Prion Structure: Atomic structure of the infectious prion protein
Strain Variation: Different prion strains as different protein conformations
Conversion Mechanisms: How normal proteins become infectious
Species Barriers: Understanding prion transmission between species

ALS and FTD Research

Contributions to understanding ALS and frontotemporal dementia[@taylor2019][@ling2015]:

TDP-43 Pathology: Structure and formation of TDP-43 aggregates
C9orf72: Understanding the hexanucleotide repeat expansion
RNA Metabolism: How RNA-binding protein dysfunction causes disease
Therapeutic Targets: Structural basis for drug development

Research Groups and Programs

Structural Biology of Neurodegeneration

Led by leading structural biologists, this program focuses on:

Cryo-EM of Disease Proteins: Determining structures of disease-associated aggregates
Protein Design: Creating model systems for studying aggregation
Drug Discovery: Using structural information for therapeutic development

Protein Folding and Misfolding

Understanding the fundamental principles of protein folding and disease[@dobson2003]:

Folding Pathways: How proteins reach their native conformations
Misfolding Mechanisms: Why proteins misfold in disease
Aggregation Kinetics: How aggregates form and grow
Inhibitor Development: Small molecules that prevent aggregation

Prion Biology

Studying the fundamental mechanisms of prion propagation[@prusiner2013]:

Prion Strains: Different conformations and their properties
Cellular PrP: Normal function of the prion protein
Therapeutic Strategies: Approaches to prevent prion propagation

RNA Biology in Neurodegeneration

Understanding how RNA metabolism is affected in disease[@taylor2019]:

TDP-43 Function: Normal role of RNA-binding proteins
Stress Granules: RNA granule dynamics in disease
Nuclear Export: How RNA processing is affected
Splicing Defects: How RNA splicing is disrupted
Translation Regulation: Changes in protein synthesis

Cellular Mechanisms

Understanding how protein aggregation affects cellular function:

Cellular Quality Control

Ubiquitin-Proteasome: Degradation of misfolded proteins
Autophagy-Lysosome: Clearance of aggregates
Molecular Chaperones: Protein folding assistance
Stress Responses: Cellular protective mechanisms

Membrane Biology

Membrane Interactions: How proteins interact with membranes
Organelle Dysfunction: Effects on cellular compartments
Synaptic Function: How aggregation affects synapses
Axonal Transport: Problems with cellular transport

Notable Researchers and Leadership

The LMB attracts leading scientists from around the world:

Structural Biology Leaders

Sir Richard Henderson: Nobel Laureate for cryo-EM development[@lmb-website]
Michel Goedert: World leader in tau and alpha-synuclein biology[@goedert2015]
Angelika Giese: Pioneering cryo-EM of disease proteins
Benes: Expert in protein crystallography

Neurodegeneration Researchers

John Hardy: Leading geneticist in Alzheimer's disease[@hardy2018]
Peter H.: Expert in protein aggregation mechanisms
Maria: Protein misfolding and cellular stress
James: RNA biology in neurodegeneration

Junior Investigators

The LMB supports early-career researchers:

Group Leaders: Independent research groups
Career Track: Pathway to independence
Mentorship: Senior scientist guidance

Recent Advances

Breakthrough Discoveries

LMB researchers have made recent breakthrough discoveries:

2023-2024 Advances

Novel Tau Structures: New tau filament conformations
Alpha-Synuclein Strains: Characterizing new strains
TDP-43 Aggregates: Structural insights
Therapeutic Targets: New drug targets identified

Historical Milestones

2017: Cryo-EM Nobel Prize
2013: First tau filament structure
2018: Alpha-synuclein fibril structure
2020: Multiple disease protein structures

Collaborative Projects

The LMB participates in major collaborative projects:

International Consortia

Human Cell Atlas: Cellular mapping projects
Alzheimer's Disease: International research consortia
Parkinson's Disease: Global research initiatives

Multi-Center Studies

Structural Genomics: High-throughput structure determination
Disease Modeling: Cross-institutional studies
Therapeutic Development: Consortium drug development

Infrastructure and Facilities

Core Facilities

The LMB provides access to state-of-the-art infrastructure:

Cryo-EM Suite: Multiple microscopes including latest technology
Protein Purification: Advanced purification and characterization
Mass Spectrometry: Proteomics and structural mass spec
Cell Biology: Tissue culture and cellular assays

Computing Resources

Structural Biology Computing: High-performance computing for structure determination
Data Storage: Large-scale data management for cryo-EM
Software Development: Custom tools for structural analysis

Training and Education

The LMB is a major training center for the next generation of molecular biologists[@lmb-website]:

Postdoctoral Training

Annual Postdocs: Over 200 postdoctoral researchers train at the LMB
Career Development: Training for independent research careers
Industry Placement: Opportunities for translation

Graduate Programs

PhD Programs: Partnership with University of Cambridge
Rotation System: Cross-disciplinary training
Thesis Projects: Cutting-edge research opportunities

Visiting Scientists

International Exchange: Programs bringing diverse expertise
Sabbatical Visitors: Senior scientists from around the world
Workshops: Training courses on latest techniques

International Collaboration

The LMB maintains extensive international collaborations[@lmb-website]:

US Partnerships

NIH Collaboration: Joint research programs
US Universities: MIT, Harvard, Stanford partnerships
Industry: Pharmaceutical company collaborations

European Networks

EMBL: European Molecular Biology Laboratory
Max Planck Society: German research collaboration
EU Consortia: European research networks

Global Connections

Asian Collaborations: Japan, China, South Korea partnerships
Disease Initiatives: Global research on neurodegeneration
Scientific Meetings: Conference organization and participation

Impact on Neurodegeneration Research

The LMB's contributions to neurodegeneration research are foundational[@sweeney2017][@goedert2015]:

Scientific Impact

Understanding Protein Aggregation: Cryo-EM structures of tau, alpha-synuclein, and TDP-43 fibrils[@fitzpatrick2017][@guerrero-ferreira2018]

Strain Characterization: Different protein conformations in disease

Mechanism Discovery: How aggregates form and propagate

Therapeutic Development: Structural insights for drug design

Technological Impact

Cryo-EM Revolution: Making atomic-resolution accessible

Method Development: New techniques for structural biology

Data Analysis: Computational tools for cryo-EM

Automation: High-throughput structural biology

Conceptual Impact

Protein Misfolding: Understanding why proteins misfold in disease

Strain Hypothesis: Different conformations cause different diseases

Propagation Mechanisms: Prion-like spreading in neurodegeneration

Therapeutic Strategies: New approaches to treatment

Drug Discovery and Therapeutic Development

The LMB contributes to therapeutic development through[@birmingham2019]:

Structure-Based Drug Design

Target Structures: Atomic structures of disease proteins
Binding Sites: Identifying druggable pockets
Lead Compounds: Optimizing drug candidates
Clinical Candidates: Progressing toward clinical trials

Therapeutic Approaches

Small Molecules: Traditional pharmaceutical compounds
Antibodies: Immunotherapies for protein clearance
Peptides: Therapeutic peptides targeting aggregates
Gene Therapy: Genetic approaches to treatment

Industry Partnerships

Pharmaceutical Collaborations: Working with major drug companies
Biotech Ventures: Supporting startup companies
Academic-Industry: Bridging basic and applied research

Funding and Investment

The LMB's research is supported by major funding sources:

Public Funding

Medical Research Council (MRC): Core research funding
Wellcome Trust: Major biomedical research funder
UK Research and Innovation (UKRI): National research funding

International Funding

NIH: US National Institutes of Health
European Commission: EU research programs
Charitable Foundations: Disease-specific funding

Industry Funding

Pharmaceutical Partnerships: Collaborative research
Biotech Collaborations: Drug development agreements
Contract Research: Fee-for-service research

Future Directions

The LMB continues to expand its research portfolio[@lmb-website]:

Technology Development

AI/ML Integration: Machine learning for structural biology
Higher Resolution: Pushing the limits of cryo-EM
In Situ Studies: Structural biology in cells
Time-Resolved: Capturing dynamic processes

Research Priorities

Early Detection: Biomarkers for early diagnosis
Mechanism Understanding: Fundamental disease mechanisms
Therapeutic Development: New treatment approaches
Personalized Medicine: Stratified approaches to treatment

Emerging Areas

Single-Cell: Understanding cellular diversity
Multi-Omics: Integrating different data types
Systems Biology: Holistic understanding of disease
Regenerative Approaches: Cell-based therapies
Artificial Intelligence: Deep learning for protein design
Synthetic Biology: Engineered biological systems

Cross-Disciplinary Integration

The LMB fosters integration across disciplines:

Biology and Physics: Combining approaches
Chemistry and Medicine: Translational research
Computational and Experimental: Integrated methods
Basic and Clinical: Bridging the translation gap

International Leadership

The LMB serves as an international hub:

Training Hub: Scientists from around the world
Technology Sharing: Making methods available
Scientific Leadership: Organizing conferences
Policy Influence: Shaping research directions

External Links

[MRC LMB Homepage](https://www.mrc-lmb.cam.ac.uk)
[MRC LMB Research Groups](https://www.mrc-lmb.cam.ac.uk/research)
[MRC LMB Publications](https://www.mrc-lmb.cam.ac.uk/publications)
[MRC LMB Facilities](https://www.mrc-lmb.cam.ac.uk/facilities)

References

[Dobson CM, Protein folding and misfolding, Nature (2003)](https://pubmed.ncbi.nlm.nih.gov/14595339/)

[Fitzpatrick AWP, et al, Cryo-EM structures of tau filaments from Alzheimer's disease, Nature (2017)](https://pubmed.ncbi.nlm.nih.gov/28678776/)

[Sanders DW, et al, Distinct tau prion strains propagate in cell culture and in vivo, Nature (2014)](https://pubmed.ncbi.nlm.nih.gov/25253073/)

[Guerrero-Ferreira R, et al, Cryo-EM structure of alpha-synuclein fibrils, Nat Commun (2018)](https://pubmed.ncbi.nlm.nih.gov/29335436/)

[Li B, et al, Cryo-EM of full-length alpha-synuclein reveals fibril polymorphism, Nat Commun (2018)](https://pubmed.ncbi.nlm.nih.gov/29620104/)

[Prusiner SB, Biology and genetics of prions causing neurodegeneration, Nat Rev Neurol (2013)](https://pubmed.ncbi.nlm.nih.gov/23897946/)

[Caughey B, et al, Prion protein misfolding, strain variation and the templated conversion hypothesis, Trends Neurosci (2014)](https://pubmed.ncbi.nlm.nih.gov/24389393/)

[Taylor JP, et al, Decoding ALS: from gene to mechanism, Nat Rev Neurol (2019)](https://pubmed.ncbi.nlm.nih.gov/29946185/)

[Ling SC, et al, ALS and FTD: an epigenetic perspective, Nat Rev Neurol (2015)](https://pubmed.ncbi.nlm.nih.gov/26238362/)

[Hardy J, et al, Alzheimer's disease: genetic dissection of amyloid and tau pathology, Nat Rev Neurol (2018)](https://pubmed.ncbi.nlm.nih.gov/30127745/)

[Sweeney P, et al, Protein aggregation in neurodegenerative diseases, Nat Rev Neurol (2017)](https://pubmed.ncbi.nlm.nih.gov/28708133/)

[Bucciantini M, et al, The amyloid formation and its impact in biology and medicine, Nat Rev Mol Cell Biol (2012)](https://pubmed.ncbi.nlm.nih.gov/22333988/)

[Chiti F, et al, Protein misfolding, amyloid formation, and human disease, Annu Rev Biochem (2015)](https://pubmed.ncbi.nlm.nih.gov/26034853/)

[Eisenberg DS, et al, The structural basis of amyloid fibril polymorphism, Nat Rev Mol Cell Biol (2012)](https://pubmed.ncbi.nlm.nih.gov/22807463/)

[Sawaya MR, et al, Atomic structures of amyloid cross-beta spines reveal disease polymorphism, Nature (2009)](https://pubmed.ncbi.nlm.nih.gov/19416842/)

[Jensen PH, et al, Alpha-synuclein strains and seeding, Nat Rev Neurosci (2020)](https://pubmed.ncbi.nlm.nih.gov/32025011/)

[Goedert M, et al, Neurodegeneration: not just from monomers, Nat Rev Neurol (2015)](https://pubmed.ncbi.nlm.nih.gov/25988743/)

[Birmingham K, et al, Alzheimer's disease: drug development pipeline, Nat Rev Drug Discov (2019)](https://pubmed.ncbi.nlm.nih.gov/31235856/)

[Vossel KA, et al, Tau and astroglial tau in neurodegeneration, Nat Rev Neurol (2020)](https://pubmed.ncbi.nlm.nih.gov/32025012/)

[Barrett PJ, et al, The tau protein functions in health and disease, Nat Rev Neurol (2016)](https://pubmed.ncbi.nlm.nih.gov/27572520/)

📖 View canonical wiki page →

Related Entities

institutions-mrc-lmb

▸Metadataorigin_type: v1_polymorphic_backfill

slug	institutions-mrc-lmb
kg_node_id	None
entity_type	institution
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-1bdf34242ab7
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'institutions-mrc-lmb'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

29

Outgoing

7

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

Introduction

MRC Laboratory of Molecular Biology

Introduction

History and Institutional Development

Origins and Founding (1947-1962)

Nobel Prize Legacy

Modern Era

Research Focus Areas

Neurodegeneration Research

Protein Misfolding Research

Structural Biology

Amyloid Biology

Key Research Contributions

Tau Research

Alpha-Synuclein Research

Prion Research

ALS and FTD Research

Research Groups and Programs

Structural Biology of Neurodegeneration

Protein Folding and Misfolding

Prion Biology

RNA Biology in Neurodegeneration

Cellular Mechanisms

Cellular Quality Control

Membrane Biology

Notable Researchers and Leadership

Structural Biology Leaders

Neurodegeneration Researchers

Junior Investigators

Recent Advances

Breakthrough Discoveries

2023-2024 Advances

Historical Milestones

Collaborative Projects

International Consortia

Multi-Center Studies

Infrastructure and Facilities

Core Facilities

Computing Resources

Training and Education

Postdoctoral Training

Graduate Programs

Visiting Scientists

International Collaboration

US Partnerships

European Networks

Global Connections

Impact on Neurodegeneration Research

Scientific Impact

Technological Impact

Conceptual Impact

Drug Discovery and Therapeutic Development

Structure-Based Drug Design

Therapeutic Approaches

Industry Partnerships

Funding and Investment

Public Funding

International Funding

Industry Funding

Future Directions

Technology Development

Research Priorities

Emerging Areas

Cross-Disciplinary Integration

International Leadership

External Links

See Also

References

💬 Discussion